Insight Molecular Diagnostics (IMDX) Return on Capital Employed Growth (1y) (2017 - 2026)
Insight Molecular Diagnostics (IMDX) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -1,856.00 |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -57.00 |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -47.00 |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 1,386.00 |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 44.00 |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -76.00 |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 1,344.00 |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 2,850.00 |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -961.00 |
| 10 | Insight Molecular Diagnostics | 4.34 Mn | -24.59 Mn | 15,000.00 | -1,170.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,170.00 |
| Dec 31, 2025 | -1,824.00 |
| Sep 30, 2025 | 3,589.00 |
| Jun 30, 2025 | 2,401.00 |
| Mar 31, 2025 | 3,530.00 |
| Dec 31, 2024 | 730.00 |
| Sep 30, 2024 | -4,186.00 |
| Jun 30, 2024 | -3,535.00 |
| Mar 31, 2024 | -5,117.00 |
| Dec 31, 2023 | -1,995.00 |
| Sep 30, 2023 | 86.00 |
| Jun 30, 2023 | 1,693.00 |
| Mar 31, 2023 | 3,627.00 |
| Dec 31, 2022 | 3,410.00 |
| Sep 30, 2022 | 30.00 |
| Jun 30, 2022 | -929.00 |
| Mar 31, 2022 | -792.00 |
| Dec 31, 2021 | 1,288.00 |
| Sep 30, 2021 | 3,178.00 |
| Jun 30, 2021 | 2,684.00 |